Quotes 5-day view Delayed Nyse
09/13/2021
09/14/2021
09/15/2021
09/16/2021
09/17/2021
Date
126.62(c)
127.05(c)
127.49(c)
127.44(c)
126.93 Last
5 810 983
4 197 394
4 803 163
3 317 341
3 604 888 Volume
-1.69% +0.34% +0.35% -0.04% -0.40% Change
Estimated financial data (e) (USD)
Sales 2021
39 807 M - -
Net income 2021
5 837 M - -
Net Debt 2021
8 454 M - -
P/E ratio 2021
38,6x
Yield 2021
1,34%
Sales 2022
39 547 M - -
Net income 2022
6 412 M - -
Net Debt 2022
6 281 M - -
P/E ratio 2022
35,4x
Yield 2022
1,43%
Capitalization
226 B 226 B -
EV / Sales 2021
5,89x
EV / Sales 2022
5,87x
Nbr of Employees
109 000
Free-Float
88,8%
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products,...
Ratings of Abbott Laboratories
All news about ABBOTT LABORATORIES
09/15 ABBOTT LABORATORIES : to Pay Quarterly Cash Dividend of $0.45 a Share on Nov. 15..MT
09/15 ABBOTT : Declares 391st Consecutive Quarterly DividendPR
09/15 Abbott Laboratories Declares Quarterly Dividend, Payable on November 15, 2021 CI
09/13 GLOBAL MARKETS LIVE : Valneva, Walt Disney, ViacomCBS, General Motors, Amazon...09/13 INSIDER SELL : Abbott LaboratoriesMT
09/10 QIAGEN N : 3M, Qiagen to comply with Biden's COVID-19 vaccination, test mandateRE
09/10 QIAGEN N : supports White House COVID-19 vaccination, test mandateRE
09/08 INSIDER SELL : Abbott LaboratoriesMT
09/03 INSIDER SELL : Abbott LaboratoriesMT
09/02 ABBOTT LABORATORIES : Acquires Medical Device Company Walk VascularMT
09/02 ABBOTT : Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular..PR
09/02 Abbott Laboratories acquired Walk Vascular L.L.C. CI
09/01 ABBOTT LABORATORIES : BY-LAWS OF ABBOTT LABORATORIES (Form 8-K)PU
09/01 ABBOTT LABORATORIES : Change in Directors or Principal Officers, Amendments to A..AQ
09/01 Abbott Laboratories Names Patricia P. Gonzalez as Board of Directors CI
News in other languages on ABBOTT LABORATORIES
Analyst Recommendations on ABBOTT LABORATORIES
ABBOTT LABORATORIES - 01/20
Close to a key resistance level
BUY
Abbott Labs to pay $160 million over kickbacks, false diabetes claims to Medicare
Chart ABBOTT LABORATORIES
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ABBOTT LABORATORIES
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
24
Last Close Price
127,44 $
Average target price
130,04 $
Spread / Average Target
2,04%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
